These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26521773)

  • 1. Chemical Structure Similarity Search for Ligand-based Virtual Screening: Methods and Computational Resources.
    Yan X; Liao C; Liu Z; Hagler AT; Gu Q; Xu J
    Curr Drug Targets; 2016; 17(14):1580-1585. PubMed ID: 26521773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity.
    Quintus F; Sperandio O; Grynberg J; Petitjean M; Tuffery P
    BMC Bioinformatics; 2009 Aug; 10():245. PubMed ID: 19671127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically.
    Hu Q; Peng Z; Kostrowicki J; Kuki A
    Methods Mol Biol; 2011; 685():253-76. PubMed ID: 20981528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantum probability ranking principle for ligand-based virtual screening.
    Al-Dabbagh MM; Salim N; Himmat M; Ahmed A; Saeed F
    J Comput Aided Mol Des; 2017 Apr; 31(4):365-378. PubMed ID: 28220440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gWEGA: GPU-accelerated WEGA for molecular superposition and shape comparison.
    Yan X; Li J; Gu Q; Xu J
    J Comput Chem; 2014 Jun; 35(15):1122-30. PubMed ID: 24729358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience.
    Bragina ME; Daina A; Perez MAS; Michielin O; Zoete V
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Pharmacophore Matching, 2D Similarity Search, and In Vitro Biological Assays in the Selection of Potential 5-HT6 Antagonists from Large Commercial Repositories.
    Dobi K; Flachner B; Pukáncsik M; Máthé E; Bognár M; Szaszkó M; Magyar C; Hajdú I; Lőrincz Z; Simon I; Fülöp F; Cseh S; Dormán G
    Chem Biol Drug Des; 2015 Oct; 86(4):864-80. PubMed ID: 25823681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics-based virtual screening: accelerating the drug discovery process by high-performance computing.
    Ge H; Wang Y; Li C; Chen N; Xie Y; Xu M; He Y; Gu X; Wu R; Gu Q; Zeng L; Xu J
    J Chem Inf Model; 2013 Oct; 53(10):2757-64. PubMed ID: 24001302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FilTer BaSe: A web accessible chemical database for small compound libraries.
    Kolte BS; Londhe SR; Solanki BR; Gacche RN; Meshram RJ
    J Mol Graph Model; 2018 Mar; 80():95-103. PubMed ID: 29328995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to Prepare a Compound Collection Prior to Virtual Screening.
    Bologa CG; Ursu O; Oprea TI
    Methods Mol Biol; 2019; 1939():119-138. PubMed ID: 30848459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the chemoinformatic-based identification of DNA methyltransferase inhibitors: 2D- and 3D-similarity profile of screening libraries.
    Yoo J; Medina-Franco JL
    Curr Comput Aided Drug Des; 2012 Dec; 8(4):317-29. PubMed ID: 22734709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Virtual Screening.
    Li Q; Shah S
    Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design.
    Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G
    Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches.
    Vázquez J; López M; Gibert E; Herrero E; Luque FJ
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33076254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.
    Wei NN; Hamza A
    J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Ligand-based Big Data Deep Neural Network Models for Virtual Screening of Large Compound Libraries.
    Xiao T; Qi X; Chen Y; Jiang Y
    Mol Inform; 2018 Nov; 37(11):e1800031. PubMed ID: 29882343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Identification of Potential Drug Candidates from Multi-Million Compounds' Repositories. Combination of 2D Similarity Search with 3D Ligand/Structure Based Methods and In Vitro Screening.
    Szilágyi K; Flachner B; Hajdú I; Szaszkó M; Dobi K; Lőrincz Z; Cseh S; Dormán G
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docking methods for structure-based library design.
    Cavasotto CN; Phatak SS
    Methods Mol Biol; 2011; 685():155-74. PubMed ID: 20981523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Virtual Screening of Commercially Available Compound Libraries.
    Kireev D
    Methods Mol Biol; 2016; 1439():65-76. PubMed ID: 27316988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.